# Pharmacokinetics of Ceftazidime-avibactam Among Critically-ill Patients Receiving CVVHDF

> **NCT04358991** · — · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 20 (actual)

## Conditions studied

- Bacterial Infections

## Interventions

- **DRUG:** Ceftazidime-avibactam

## Key facts

- **NCT ID:** NCT04358991
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-09-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04358991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04358991, "Pharmacokinetics of Ceftazidime-avibactam Among Critically-ill Patients Receiving CVVHDF". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04358991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*